§ 4. 1 Fonden har til formål at foretage investeringer i fast ejendom og/eller børsnoterede værdipapirer. § 1. 4 Fondens uddelingsformål er at støtte sygdomsbekæmpelse, herunder fortrinsvis bekæmpelsen af kræft og hjertesygdomme på den måde, som efter bestyrelsens skøn er mest hensigtsmæssig. Bidrag fra fonden skal fortrinsvis ydes direkte til de pågældende og ikke til foreninger og indsamlinger.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 1.6 mio. | 10.8 mio. | 173.8 mio. | 172.3 mio. | 0 | |
CVR: 11638392
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 566 companies in Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål
Comparison is based on industry median values
Companies in the same industry and area
CVR 18695448
CVR 27390684
CVR 17509586
CVR 11613195
CVR 11581234
The financial health of ARVID NILSSONS FOND appears strong, with a notable increase in profit from 8,436,925 DKK in 2023 to 10,838,869 DKK in 2024, alongside stable revenue growth from 1,627,364 DKK to 1,647,211 DKK. Despite a challenging year in 2022, where the company reported a loss of 9,323,852 DKK, it has rebounded effectively, showcasing resilience in its operations. The equity position is robust at 172,319,959 DKK, indicating a solid foundation for future growth, although the profit margins remain a point of scrutiny given the fluctuations in previous years. Positioned within the support activities related to disease control, social, and charitable purposes, the company holds a significant role in its industry, leveraging its financial stability to further its mission.
AI-generated summary